Prognostic molecular signature of sarcomas, and uses thereof
Abstract:
Described herein are methods and compositions that can be used for diagnosis and treatment of soft tissue sarcoma cancer phenotypes and soft tissue sarcoma cancer-associated diseases. Also described herein are methods that can be used to identify modulators of soft tissue sarcoma cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0